These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 24493283)
21. In vivo and in vitro production of anti-histone antibodies in NZB/NZW mice. Gioud M; Kotzin BL; Rubin RL; Joslin FG; Tan EM J Immunol; 1983 Jul; 131(1):269-74. PubMed ID: 6863918 [TBL] [Abstract][Full Text] [Related]
22. Differences in expression of lupus nephritis in New Zealand mixed H-2z homozygous inbred strains of mice derived from New Zealand black and New Zealand white mice. Origins and initial characterization. Rudofsky UH; Evans BD; Balaban SL; Mottironi VD; Gabrielsen AE Lab Invest; 1993 Apr; 68(4):419-26. PubMed ID: 8479150 [TBL] [Abstract][Full Text] [Related]
23. Insulin resistance and obesity in a mouse model of systemic lupus erythematosus. Ryan MJ; McLemore GR; Hendrix ST Hypertension; 2006 Nov; 48(5):988-93. PubMed ID: 16982954 [TBL] [Abstract][Full Text] [Related]
24. Comparison of chlordecone effects on autoimmunity in (NZBxNZW) F(1) and BALB/c mice. Sobel ES; Wang F; Butfiloski E; Croker B; Roberts SM Toxicology; 2006 Feb; 218(2-3):81-9. PubMed ID: 16309813 [TBL] [Abstract][Full Text] [Related]
25. [Chromosome aberrations in F1 (NZBxNZW) mice--an experimental model of systemic lupus erythematosus]. Skazkina OIa; Lil'p IG; Pleskovskaia GN; Tugolukova SS; Korogodina IuV Tsitol Genet; 1984; 18(6):458-9. PubMed ID: 6441320 [TBL] [Abstract][Full Text] [Related]
26. Cross-reactivity of antiidiotypic antibodies with DNA in systemic lupus erythematosus. Eivazova ER; McDonnell JM; Sutton BJ; Staines NA Arthritis Rheum; 2000 Feb; 43(2):429-39. PubMed ID: 10693885 [TBL] [Abstract][Full Text] [Related]
27. DNA hypomethylation is crucial for apoptotic DNA to induce systemic lupus erythematosus-like autoimmune disease in SLE-non-susceptible mice. Wen ZK; Xu W; Xu L; Cao QH; Wang Y; Chu YW; Xiong SD Rheumatology (Oxford); 2007 Dec; 46(12):1796-803. PubMed ID: 18032537 [TBL] [Abstract][Full Text] [Related]
28. Interleukin-6 exacerbates glomerulonephritis in (NZB x NZW)F1 mice. Ryffel B; Car BD; Gunn H; Roman D; Hiestand P; Mihatsch MJ Am J Pathol; 1994 May; 144(5):927-37. PubMed ID: 8178944 [TBL] [Abstract][Full Text] [Related]
29. T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis. Enghard P; Langnickel D; Riemekasten G Scand J Rheumatol; 2006; 35(3):209-16. PubMed ID: 16766368 [TBL] [Abstract][Full Text] [Related]
30. Ifi202, an IFN-inducible candidate gene for lupus susceptibility in NZB/W F1 mice, is a positive regulator for NF-kappaB activation in dendritic cells. Yamauchi M; Hashimoto M; Ichiyama K; Yoshida R; Hanada T; Muta T; Komune S; Kobayashi T; Yoshimura A Int Immunol; 2007 Aug; 19(8):935-42. PubMed ID: 17702989 [TBL] [Abstract][Full Text] [Related]
31. Sophorae radix reduces autoimmune response in NZB/w F1 systemic lupus erythematosus mouse model. Ko E; Lee Y; Park N; Cho C; Yim YN; Kim J; Kim YS; Kim D; Shin MK; Hong MC; Bae H Lupus; 2007; 16(5):335-41. PubMed ID: 17576735 [TBL] [Abstract][Full Text] [Related]
32. Male New Zealand Black/KN mice: a novel model for autoimmune-induced permanent alopecia? Hiroi A; Ito T; Seo N; Uede K; Yoshimasu T; Ito M; Nakamura K; Ito N; Paus R; Furukawa F Br J Dermatol; 2006 Aug; 155(2):437-45. PubMed ID: 16882186 [TBL] [Abstract][Full Text] [Related]
33. Soluble human CD83 ameliorates lupus in NZB/W F1 mice. Starke C; Steinkasserer A; Voll RE; Zinser E Immunobiology; 2013 Nov; 218(11):1411-5. PubMed ID: 23886695 [TBL] [Abstract][Full Text] [Related]
34. Anxiety behavior, exploratory behavior, and activity in NZB x NZW F1 hybrid mice: role of genotype and autoimmune disease progression. Schrott LM; Crnic LS Brain Behav Immun; 1996 Sep; 10(3):260-74. PubMed ID: 8954598 [TBL] [Abstract][Full Text] [Related]
35. Assessment of the translational value of mouse lupus models using clinically relevant biomarkers. Bender AT; Wu Y; Cao Q; Ding Y; Oestreicher J; Genest M; Akare S; Ishizaka ST; Mackey MF Transl Res; 2014 Jun; 163(6):515-32. PubMed ID: 24462761 [TBL] [Abstract][Full Text] [Related]
36. Disease progression in the systemic lupus erythematosus model mouse (NZB/NZW F1) is inhibited by single shot estrogen treatment in the neonate. Yamaguchi K; Inoue Y; Hisano M; Unten S; Shimamura T Lupus; 2003; 12(4):332-4. PubMed ID: 12729061 [No Abstract] [Full Text] [Related]
37. Preventive effect of a novel antifolate, MX-68, in murine systemic lupus erythematosus (SLE). Mihara M; Takagi N; Urakawa K; Moriya Y; Takeda Y Int J Immunopharmacol; 1997 Feb; 19(2):67-74. PubMed ID: 9278176 [TBL] [Abstract][Full Text] [Related]
38. Evidence for pleomorphism of estrogen receptor capacity and affinity in liver and thymus of immature BALB/c and (NZBxNZW) F1 mice, a model of systemic lupus erythematosus. Roa R; Greenstein BD Int J Immunopharmacol; 2000 Nov; 22(11):897-903. PubMed ID: 11090698 [TBL] [Abstract][Full Text] [Related]
40. Impact of early life ovariectomy on blood pressure and body composition in a female mouse model of systemic lupus erythematosus. Gilbert EL; Ryan MJ Am J Physiol Regul Integr Comp Physiol; 2014 Oct; 307(8):R990-7. PubMed ID: 25324553 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]